I now have a very comprehensive set of content from Harrison's Chapter 39 (the dedicated dyspnea chapter) including mechanisms, mMRC scale, differential diagnosis table, treatment, and distinguishing cardiac from respiratory causes. I have enough to write a thorough, well-organized answer.
Shortness of Breath (SOB) / Dyspnea - Complete Clinical Review
Definition
Dyspnea is defined by the American Thoracic Society as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity." It derives from interactions among multiple physiological, psychological, social, and environmental factors. Dyspnea is a symptom - it can only be perceived and self-reported by the patient. Signs of increased work of breathing (tachypnea, accessory muscle use, intercostal retraction) are separate, observable findings.
Key terminology:
- Dyspnea - the subjective symptom itself
- Orthopnea - dyspnea worsening when supine
- Paroxysmal Nocturnal Dyspnea (PND) - severe dyspnea that awakens the patient from sleep
- Trepopnea - dyspnea in one lateral decubitus position
- Platypnea - dyspnea that worsens when sitting upright (improves when lying)
(Harrison's Principles of Internal Medicine 22E, Chapter 39)
Epidemiology
- Present in up to 50% of inpatients and 25% of ambulatory patients
- Community prevalence: 9-13%, rising to 37% in adults ≥70 years
- Accounts for 3-4 million emergency visits per year
- Dyspnea predicts outcomes in COPD better than FEV1 alone (incorporated into GOLD guidelines)
- Post-COVID syndrome is now an increasingly recognized cause
Mechanisms (Pathophysiology)
Dyspnea can arise via three main pathways:
1. Afferent Signals (Sensory Input to CNS)
- Chemoreceptors: Peripheral (carotid body, aortic arch) and central (medulla) receptors activated by hypoxemia, hypercapnia, or acidemia → produces "air hunger"
- Mechanoreceptors:
- Lungs: stretch receptors, irritant receptors, J receptors
- Chest wall: muscle spindles and tendon organs
- Activation by increased airway resistance → "chest tightness" (e.g., asthma, COPD)
- Reduced lung compliance → "increased effort" (e.g., pulmonary fibrosis)
2. Efferent Signals (CNS to Respiratory Muscles)
Motor commands from the brain to respiratory muscles generate a sense of effort
3. Efferent-Reafferent Mismatch (Most Important)
When the expected motor output does not match the sensory feedback received, dyspnea is magnified. This "neuromechanical uncoupling" is central to many disease states.
(Harrison's, Chapter 39)
Clinical Features and History Taking
When assessing SOB, evaluate 7 key characteristics:
- Location (chest tightness vs. throat tightness)
- Quality - patient's own words are diagnostic:
- "Chest tightness / inability to get a deep breath" → Obstructive lung disease (asthma, COPD)
- "Air hunger / urge to breathe" → Heart failure
- "Increased effort / heavy breathing" → Neuromuscular disease, deconditioning
- "Suffocating / choking" → Laryngeal disease, upper airway obstruction
- Intensity - mMRC grade (see below)
- Temporality - onset, duration, progression
- Aggravating factors (exertion, supine position, allergens, smoke)
- Alleviating factors (rest, sitting upright, bronchodilators, diuretics)
- Associated symptoms (cough, wheeze, fever, leg edema, chest pain, hemoptysis)
Tempo of Onset
| Onset | Likely Cause |
|---|
| Acute (minutes) | Laryngeal edema, bronchospasm, pulmonary edema, pneumothorax, PE, cardiac ischemia |
| Subacute (hours-days) | Pneumonia, acute bronchitis, worsening heart failure |
| Chronic/Progressive | COPD, IPF, HF, anemia, pulmonary hypertension |
| Episodic/Intermittent | Asthma (triggered by allergens, infections) |
(Murray & Nadel's Textbook of Respiratory Medicine; Harrison's)
Special Types of Dyspnea
| Type | Description | Classic Cause |
|---|
| Orthopnea | Worsens when lying supine; improves when upright | Left heart failure, COPD |
| PND | Awakens patient at night; forces sitting or standing | Left ventricular failure |
| Instant orthopnea | Cannot assume supine position at all | Bilateral diaphragm paralysis |
| Trepopnea | Worse in one lateral position | Large pleural effusion, unilateral lung disease |
| Platypnea | Worse when sitting up, better lying down | Hepatopulmonary syndrome, ASD (rare) |
| Exertional dyspnea | Only with activity | Early cardiac or lung disease; deconditioning |
(Murray & Nadel's; Goldman-Cecil Medicine)
Differential Diagnosis
Pulmonary and cardiac causes account for up to 85% of all dyspnea cases. Up to one-third of patients have multifactorial causes.
Pulmonary Causes
| Category | Examples |
|---|
| Obstructive airways | Asthma, COPD, bronchiectasis, upper airway obstruction |
| Parenchymal | IPF, sarcoidosis, pneumonia, pulmonary edema |
| Pleural | Pleural effusion, pneumothorax, hemothorax |
| Chest wall / neuromuscular | Kyphoscoliosis, ALS, GBS, myasthenia gravis |
| Pulmonary vascular | Pulmonary embolism, pulmonary arterial hypertension |
| Malignancy | Lung cancer (primary or metastatic), lymphangitic carcinomatosis |
Cardiac Causes
| Category | Examples |
|---|
| Systolic dysfunction | Heart failure (HFrEF) post-MI, dilated cardiomyopathy |
| Diastolic dysfunction | HFpEF, hypertensive heart disease |
| Ischemia | Acute coronary syndrome, angina |
| Valvular disease | Mitral stenosis/regurgitation, aortic stenosis |
| Pericardial | Pericardial tamponade, constrictive pericarditis |
| Arrhythmia | Rapid AF, SVT |
Other Causes (Non-Cardiopulmonary)
| System | Examples |
|---|
| Hematologic | Severe anemia, methemoglobinemia, CO poisoning |
| Metabolic | Diabetic ketoacidosis (Kussmaul breathing), thyrotoxicosis |
| Neuromuscular | ALS, diaphragm paralysis, Guillain-Barré |
| Psychological | Anxiety/panic disorder (hyperventilation), functional dyspnea |
| Deconditioning | Obesity, sedentary state (feeling of heavy breathing, need to breathe more) |
| Post-COVID | Persistent breathlessness syndrome |
(Harrison's Table 39-2; Goldman-Cecil Medicine)
Grading Severity: Modified MRC Dyspnea Scale
| Grade | Description |
|---|
| 0 | Dyspnea only with strenuous exercise |
| 1 | Dyspnea on walking slightly uphill or on level |
| 2 | Walks slower than peers on level; must stop to rest at own pace |
| 3 | Stops after ~100 m or a few minutes on level ground |
| 4 | Too breathless to leave house; breathless with ADLs (dressing) |
This scale is incorporated into the GOLD COPD severity classification. (Harrison's, mMRC Table 39-1)
Physical Examination
Key findings to look for:
| Finding | Suggests |
|---|
| Tachypnea, accessory muscle use, retractions | Severe respiratory distress, airflow obstruction |
| Wheezing | Asthma, COPD, cardiac asthma |
| Crackles (bibasilar) | Heart failure, pulmonary fibrosis |
| Absent breath sounds unilaterally | Pneumothorax, large effusion |
| JVD, S3 gallop, peripheral edema | Heart failure |
| Dullness to percussion | Pleural effusion, consolidation |
| Barrel chest, pursed-lip breathing | COPD/emphysema |
| Cyanosis | Severe hypoxia |
| Clubbing | IPF, lung cancer, bronchiectasis, cyanotic heart disease |
| Pulsus paradoxus (>10 mmHg drop on inspiration) | Cardiac tamponade, severe asthma |
Diagnostic Workup
Initial Studies (for All Patients)
- Pulse oximetry - SpO2 assessment (resting, activity, sleep)
- Chest X-ray - cardiomegaly, infiltrates, effusion, pneumothorax, hyperinflation
- ECG - ischemia, arrhythmia, RV strain (PE), LV hypertrophy
- CBC - anemia, leukocytosis (infection)
- BNP / NT-proBNP - heart failure screening (excellent sensitivity)
- ABG or VBG - hypoxemia, hypercapnia, acidosis
Second-Tier Studies
| Test | Indication |
|---|
| Pulmonary function tests (PFTs) | Distinguish obstructive vs restrictive vs vascular |
| D-dimer / CT-PA | Suspected PE |
| Echocardiogram | Systolic/diastolic dysfunction, valvular disease, pericardial disease |
| High-resolution CT chest | Parenchymal lung disease (ILD, emphysema, bronchiectasis) |
| Peak flow / spirometry | Asthma, COPD diagnosis |
| Thyroid function tests | Thyrotoxicosis |
| Exercise test (CPET) | Unclear etiology despite initial workup |
PFT Interpretation in Dyspnea
| Pattern | Key Finding | Diagnosis |
|---|
| Obstructive | ↓ FEV1/FVC, TLC normal/↑, RV ↑ | COPD, asthma |
| Restrictive | ↓ TLC, ↓ FVC, normal FEV1/FVC | IPF, chest wall disease, neuromuscular |
| Mixed | Both FEV1/FVC ↓ and TLC ↓ | Combined disease |
| DLCO ↓ | Reduced diffusing capacity | Emphysema, IPF, pulmonary HTN |
(Symptom to Diagnosis, Table 15-8)
Distinguishing Cardiac vs Respiratory Dyspnea
| Feature | Cardiac | Respiratory |
|---|
| BNP | Elevated | Normal (unless cor pulmonale) |
| PFTs | Normal | Obstructive or restrictive |
| Echo | Reduced EF, elevated filling pressures | Normal (unless pulmonary HTN) |
| CXR | Cardiomegaly, pulmonary vascular congestion | Hyperinflation, infiltrates, fibrosis |
| Response to diuretics | Rapid improvement | Minimal effect |
| CPET | HR >85% max, early AT, ↓ O2 pulse, BP drop, ECG changes | Max ventilation achieved, ↑ dead space, hypoxemia, bronchospasm |
Cardiopulmonary Exercise Test (CPET) is the gold standard when both systems are involved and the cause remains unclear after initial workup. (Harrison's, Chapter 39)
Treatment Principles
1. Treat the Underlying Cause (First Priority)
- Heart failure → diuretics, ACEi/ARNi, beta-blockers, device therapy
- Asthma/COPD → bronchodilators, ICS, smoking cessation
- PE → anticoagulation, thrombolysis
- Anemia → transfusion, iron replacement
- Pneumothorax → chest tube / aspiration
2. Supplemental Oxygen
- Indicated when SpO2 <88% at rest, on activity, or during sleep
- Improves mortality in COPD with hypoxemia (landmark studies)
3. Pulmonary Rehabilitation
- Improves dyspnea, exercise capacity, and hospitalization rates in COPD
- Home/community programs (yoga, Tai Chi) also show positive effects
- Exercise programs improve outcomes in post-COVID dyspnea
4. Symptom Management (When Cause Not Fully Reversible)
- Opioids (low dose): Reduce air hunger by suppressing respiratory drive and cortical activity. Benefit is individual; routine use in COPD not supported by recent RCTs (BEAMS trial - JAMA 2022)
- Anxiolytics: No consistent benefit in studies; use cautiously
- Fan therapy: Cool air blown across the face stimulates trigeminal receptors and reduces perceived dyspnea - simple, effective palliative measure
- High-flow nasal oxygen (HFNO): Often used as bridge therapy in malignancy/end-stage disease
5. Palliative Care
In advanced disease (cancer, COPD, heart failure end-stage), dyspnea predicts survival of days to weeks - warrants serious illness conversations, advance directives, and early palliative care referral.
Red Flag Signs (Requiring Urgent/Emergency Evaluation)
- SpO2 <90% on room air
- Acute onset at rest
- Stridor (upper airway obstruction)
- Absent breath sounds (tension pneumothorax)
- JVD + muffled heart sounds + hypotension (Beck's triad - tamponade)
- RR >30/min with accessory muscle use
- Cyanosis
- Inability to speak full sentences
- Associated chest pain (ACS, PE, aortic dissection)
Summary: Bedside Framework for SOB
SOB Patient
├── Acute onset → PE, pneumothorax, ACS, flash pulmonary edema, anaphylaxis
├── Chronic/progressive → COPD, HF, ILD, anemia, pulmonary HTN
├── Episodic → Asthma, anxiety/panic, paroxysmal arrhythmia
├── Nocturnal (PND/orthopnea) → Left heart failure
├── Exertional only → Early HF, COPD, anemia, deconditioning
└── At rest → Severe disease, metabolic crisis, psychogenic
Sources:
- Harrison's Principles of Internal Medicine 22E, Chapter 39: Dyspnea
- Murray & Nadel's Textbook of Respiratory Medicine, Chapter on Clinical Assessment
- Goldman-Cecil Medicine, Chapter 39: Approach to Cardiovascular Disease
- Symptom to Diagnosis: An Evidence-Based Guide, 4th Edition, Chapter 15: Dyspnea